{"id":386487,"date":"2020-11-23T06:53:25","date_gmt":"2020-11-23T11:53:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386487"},"modified":"2020-11-23T06:53:25","modified_gmt":"2020-11-23T11:53:25","slug":"eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/","title":{"rendered":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32<sup>nd<\/sup> Annual Virtual Healthcare Conference Available for Viewing<\/b><\/p>\n<p>WOODCLIFF LAKE, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (\u201cEagle\u201d or the \u201cCompany\u201d) today announced that the Company\u2019s pre-recorded presentation at the Piper Sandler 32<sup>nd<\/sup> Annual Virtual Healthcare Conference is now available for viewing via the link below:\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpipersandler.zoom.us%2Frec%2Fplay%2F0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg&amp;esheet=52334420&amp;newsitemid=20201123005631&amp;lan=en-US&amp;anchor=https%3A%2F%2Fpipersandler.zoom.us%2Frec%2Fplay%2F0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg&amp;index=1&amp;md5=a3359f80bf624be48f00d227a58af8ea\">https:\/\/pipersandler.zoom.us\/rec\/play\/0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg<\/a><\/p>\n<p>\nIt is also available on the<b><i \/><\/b>Company\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.eagleus.com&amp;esheet=52334420&amp;newsitemid=20201123005631&amp;lan=en-US&amp;anchor=www.eagleus.com&amp;index=2&amp;md5=991e5dbeba3f6d53123c310e102ac556\">www.eagleus.com<\/a>, under the Investors section, where it will be archived for 30 days.\n<\/p>\n<p><span style=\"font-weight:normal\">Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will be participating in 1&#215;1 meetings on December 1, 2020. Meetings can be requested exclusively via Piper Sandler.<\/span><\/p>\n<p><b>About Eagle Pharmaceuticals, Inc.<\/b><\/p>\n<p>\nEagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients\u2019 lives. Eagle\u2019s commercialized products include RYANODEX<sup>\u00ae<\/sup>, BENDEKA<sup>\u00ae<\/sup>, BELRAPZO<sup>\u00ae<\/sup>, and its oncology and CNS\/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.eagleus.com&amp;esheet=52334420&amp;newsitemid=20201123005631&amp;lan=en-US&amp;anchor=www.eagleus.com&amp;index=3&amp;md5=e538c425e47cfd3d2e80667213e1e540\">www.eagleus.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201123005631\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201123005631\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations for Eagle Pharmaceuticals, Inc.:<br \/>\n<\/b><br \/>Lisa M. Wilson<br \/>\n<br \/>In-Site Communications, Inc.<br \/>\n<br \/>T: 212-452-2793<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:lwilson@insitecony.com\">lwilson@insitecony.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New Jersey United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201123005631\/en\/657949\/3\/EAGLE_Logo_Blue_2018.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing WOODCLIFF LAKE, N.J.&#8211;(BUSINESS WIRE)&#8211; Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (\u201cEagle\u201d or the \u201cCompany\u201d) today announced that the Company\u2019s pre-recorded presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference is now available for viewing via the link below: https:\/\/pipersandler.zoom.us\/rec\/play\/0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg It is also available on theCompany\u2019s website at www.eagleus.com, under the Investors section, where it will be archived for 30 days. Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will be participating in 1&#215;1 meetings on December 1, 2020. Meetings can be requested exclusively via Piper Sandler. About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386487","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing WOODCLIFF LAKE, N.J.&#8211;(BUSINESS WIRE)&#8211; Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (\u201cEagle\u201d or the \u201cCompany\u201d) today announced that the Company\u2019s pre-recorded presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference is now available for viewing via the link below: https:\/\/pipersandler.zoom.us\/rec\/play\/0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg It is also available on theCompany\u2019s website at www.eagleus.com, under the Investors section, where it will be archived for 30 days. Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will be participating in 1&#215;1 meetings on December 1, 2020. Meetings can be requested exclusively via Piper Sandler. About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing &hellip; Continue reading &quot;Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-23T11:53:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing\",\"datePublished\":\"2020-11-23T11:53:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/\"},\"wordCount\":269,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/\",\"name\":\"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-23T11:53:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/","og_locale":"en_US","og_type":"article","og_title":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk","og_description":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing WOODCLIFF LAKE, N.J.&#8211;(BUSINESS WIRE)&#8211; Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (\u201cEagle\u201d or the \u201cCompany\u201d) today announced that the Company\u2019s pre-recorded presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference is now available for viewing via the link below: https:\/\/pipersandler.zoom.us\/rec\/play\/0TlXfXVGZ3QG7IgEE4PyzFEfiG8HyD57XqSaO9Uq1Rsb_J29jmyS2ZvqWskPC1MJPA_AP6kFUMjJQfFd.vyuNfKmJI0FvhIOg It is also available on theCompany\u2019s website at www.eagleus.com, under the Investors section, where it will be archived for 30 days. Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will be participating in 1&#215;1 meetings on December 1, 2020. Meetings can be requested exclusively via Piper Sandler. About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing &hellip; Continue reading \"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-23T11:53:25+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing","datePublished":"2020-11-23T11:53:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/"},"wordCount":269,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/","name":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-23T11:53:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201123005631r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-presentation-at-piper-sandler-32nd-annual-virtual-healthcare-conference-available-for-viewing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eagle Pharmaceuticals\u2019 Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386487"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386487\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}